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cochlea. We conclude, therefore, that activin signaling is not 
necessary for hearing in adult mice under physiological con-
ditions but may be important during and after damaging 
events in the inner ear.  © 2014 S. Karger AG, Basel 
 Introduction 
 Activin has initially been discovered in the 1980s as an 
important regulator of reproduction, inducing follicle-
stimulating hormone release from the pituitary gland. In 
recent years activin, a dimeric protein belonging to the 
transforming growth factor TGF-β superfamily, was 
found to play an important role in the development, re-
pair and apoptosis of different tissues and organs [Ageta 
and Tsuchida, 2011; Weiskirchen et al., 2009; Werner and 
Alzheimer, 2006]. The detailed effects of this pluripotent 
cytokine on the homeostasis of various cells seem to be 
tissue specific [Sulyok et al., 2004].
 Activins are dimeric proteins consisting of two 
β-subunits, which are connected by disulfide bonds 
[Werner and Alzheimer, 2006]. There are different forms 
of activin: homodimeric activin A (βA-βA) and activin B 
(βB-βB), as well as heterodimeric activin AB (βA-βB). 
 Key Words 
 Inner ear · Activin receptor · Hearing · Organ of Corti · 
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 Abstract 
 Activin, a member of the TGF-β superfamily, was found to 
play an important role in the development, repair and apop-
tosis of different tissues and organs. Accordingly, activin sig-
naling is involved in the development of the cochlea. Activin 
binds to its receptor ActRII, then dimerizes with ActRI and 
induces a signaling pathway resulting in gene expression. A 
study reported a case of fibrodysplasia ossificans progressi-
va with an unusual mutation in the ActRI gene leading to 
sensorineural hearing loss. This draws attention to the role 
of activin and its receptors in the developed cochlea. To 
date, only the expression of ActRII is known in the adult 
mammalian cochlea. In this study, we present for the first 
time the presence of activin A and ActRIB in the adult co-
chlea. Transgenic mice with postnatal dominant-negative 
ActRIB expression causing disruption of activin signaling in 
vivo were used for assessing cochlear morphology and hear-
ing ability through the auditory brainstem response (ABR) 
threshold. Nonfunctioning ActRIB did not affect the ABR 
thresholds and did not alter the microscopic anatomy of the 
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Other yet poorly characterized members of the activin 
family include activin βC, βD and βE [Phillips, 2003; 
Werner and Alzheimer, 2006]. The physiological func-
tion of activin is mainly based on studies of activin A 
[Gold and Risbridger, 2012]. Activin A is deemed to be a 
stable classical morphogen among the different forms of 
its kind [Feijen et al., 1994]. In vitro and in vivo studies 
have established a neuroprotective role of activin, espe-
cially for activin A (βA-βA) [Abdipranoto-Cowley et al., 
2009; Sulyok et al., 2004]. Additional studies describe ac-
tivin A elevation, higher than other activin subtypes, dur-
ing wound reparation [Werner and Alzheimer, 2006]. 
Activin mediates its biological effect through transmem-
brane receptor serine/threonine kinases [Werner and Al-
zheimer, 2006]. Activin initially binds to type II activin 
receptors (ActRIIA/ACVRIIA or ActRIIB/ACVRIIB) on 
the cell and subsequently recruits type I activin receptors, 
mostly and preferably ActRIB (ALK4/ACVRIB) [de 
Caestecker, 2004; Müller et al., 2006; Werner and Al-
zheimer, 2006]. Other less important type I receptors in-
clude ActRIA (ALK2/ACVRI) and ActRIC (ALK7/
ACVRIC), with a low affinity to activin binding. Upon 
activin linking with the heteromeric type II receptor, it 
dimerizes with a type I receptor through its serine/threo-
nine kinase domain, causing the phosphorylation of the 
type I receptor. Subsequently, the now activated type I 
receptor phosphorylates the drafted mother against deca-
pentaplegic homolog (Smad) proteins, namely Smad2 
and Smad3, which function as intracellular mediators of 
the TGF- β pathway. The latter bind to Smad4 and trans-
locate to the nucleus, where they regulate the expression 
of activin target genes [Müller et al., 2006; Werner and 
Alzheimer, 2006]. Aside from this, other signaling path-
ways are also activated by activin receptors (e.g. extracel-
lular signal-regulated kinases, c-Jun N-terminal kinase, 
p38 mitogen-activated kinase) [ten Dijke and Hill, 2004; 
Werner and Alzheimer, 2006]. Activated activin target 
genes endorse a range of local events such as stimulation, 
modulation, regulation, migration, inhibition, protec-
tion, production, and so forth [Werner and Alzheimer, 
2006]. Interestingly, activin has a significant function in 
the brain; it is highly expressed in the central nervous sys-
tem and has crucial roles in neuronal development [Tsu-
chida et al., 2009]. Furthermore, its production is elevated 
after acute brain injury and during inflammation or isch-
emic stress [Florio et al., 2007; Müller et al., 2006]. It is 
becoming evident that activin extends its role beyond be-
ing neurotrophic and neuroprotective to being involved 
in daily operations of the synaptic network [Krieglstein et 
al., 2011].
 Recent studies reported a significant function of ac-
tivin in the early development of mammals. Natale et al. 
[2009] displayed that activin is in control of the differen-
tiation or maintenance of cells in the developing mouse. 
It has been observed that ActRIB-deficient mice resulted 
in early embryonic lethality and displayed cell disorgani-
zation in embryonic development [Gu et al., 1998]. Fur-
thermore, it has been indicated that activin signaling is 
involved in the development and organogenesis of the co-
chlea and other tissues in the growing mouse [Liu et al., 
2007].
 Concerning the role of activin in the mature cochlea, 
McCullar et al. [2010] presented the expression of activin 
type II receptors in the mature avian auditory sensory ep-
ithelium and demonstrated sensory epithelial cell prolif-
eration by activin receptor agonist treatment in vitro 
(whereas blocking the receptors inhibits proliferation). 
This supports ActRIIA/B responsiveness in mature avian 
auditory sensory epithelium [McCullar et al., 2010]. It is 
known that nonmammalian vertebrates such as birds are, 
in contrast to humans or other mammals, able to restore 
inner ear hair cells and therefore reestablish hearing and 
balance functions to near-normal levels after inner ear 
trauma. In adult mammals, a limited presence of type II 
receptors (ActRIIA, ActRIIB) in auditory sensory epithe-
lium was found [McCullar et al., 2010]. Namely,  ActRIIA 
is expressed in spiral ganglion cell bodies only and 
 ActRIIB is expressed strictly in auditory support cells 
(pillar cells only), and not in auditory hair cells. However, 
ActRII does not operate directly but requires type I recep-
tors to enable the signaling cascade [ten Dijke and Hill, 
2004; Werner and Alzheimer, 2006]. Little is known re-
garding its specific function in the mammalian cochlea 
and it is unknown whether activins or type I activin re-
ceptors, which are necessary for signal transduction, are 
expressed in the adult mammalian cochlea in the first 
place. This raises the question about the significance of 
activin type II receptor presence in the postdevelopmen-
tal mammalian inner ear. 
 In this study, we report for the first time the presence 
of activin A and ActRIB in the adult mammalian co-
chlea. To explore the role of endogenous activin in the 
mature cochlea, we used transgenic (tg) mice with a 
dominant-negative ActRIB mutation (dnActRIB) in a 
truncated manner, resulting in disruption of the activin 
receptor signaling in vivo and therefore unperceptive to 
the influence of activin through type I receptors, par-
ticularly ActRIB [Müller et al., 2006; Zhou et al., 2000]. 
Since the truncated ActRIB form inactive complexes 
with ActRII, the subsequent downstream signal trans-
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duction is efficiently inhibited, and hence the subse-
quent Smad activation is absent. [Müller et al., 2006; 
Zhou et al., 2000]. The tg mice were generated using cal-
cium/calmodulin-dependent protein kinase (CaMKII-α 
promoter), resulting in nonfunction of ActRIB in the 
forebrain, cortex and amygdala [Müller et al., 2006]. The 
dominant-negative effect of the transgene was verified 
in vivo  by injecting activin A intracerebroventricularly 
and measuring the phosphorylation of Smad2. Activin 
A reproducibly increased the levels of pSmad2 in wild-
type (wt) mice, whereas no increase in the levels of 
 pSmad2 was observed in tg mice [Müller et al., 2006]. 
Because the CaMKII-α promoter is likewise widely ex-
pressed in the cochlea [Agrup et al., 1997; Minamino et 
al., 1998; Puschner and Schacht, 1997], we assumed an 
analogous dominant-negative effect of ActRIB also in 
the cochlea. Therefore, this tg construct enabled us to 
explore the effect of activin signaling disruption in the 
adult cochlea in vivo without interfering with prenatal 
and early postnatal development of the mouse, as the 
activity of the CaMKII-α-promoter is not seen before 
the second postnatal week [Müller et al., 2006]. Further-
more, we performed histological and functional analysis 
to assess the physiological role of activin in the mamma-
lian cochlea. Interestingly, mice with disrupted activin 
signaling had normal hearing and ordinary histological 
structure of the cochlea. Hence, we conclude that activin 
signaling is nonrelevant for hearing in physiological cir-
cumstances in adult mice.
 Materials and Methods 
 All animal procedures were carried out according to our ap-
proved animal research protocols (Kantonales Veterinäramt 
 Zurich and Basel, Switzerland). We used newborn (2–5 days old) 
and adult (8 weeks old) Sprague-Dawley rats (Harlan, The 
 Netherlands) and 10-week-old wt and tg adult C57BL/6 mice 
(kindly provided by Sabine Werner, Institute of Cell Biology, ETH 
Zurich, Switzerland), as described previously [Müller et al., 2006].
 Organ Culture and RNA Extraction 
 This method has been described previously [Caelers et al., 
2009].
 The 2- to 5-day-old rats were sacrificed and cochlear micro-
dissections were performed to separate the organ of Corti from 
the spiral ganglion, stria vascularis and Reissner membrane 
[Sobkowicz et al., 1993]. Following isolation, all organs of Corti 
were transferred to cell culture plates and maintained on 0.4-
mm culture plate inserts (Millipore AG, Switzerland) in Dul-
becco’s modified Eagle’s medium with 25 m M of HEPES supple-
mented with 10% fetal calf serum and 30 U/ml penicillin (all 
Invitrogen AG, Switzerland). After culturing 5 organs of Corti, 
ganglions and stria, they were transferred to RNAlater solution 
(Qiagen AG, Switzerland, catalog No. 76106). RNAlater solution 
prevents mRNA from being degraded. RNA isolation was then 
performed using the RNeasy RNA Mini Kit (Qiagen AG, 
 Switzerland, catalog No. 74104) using the tissue homogenizer 
Ultra-Turrax T8 (IKA-Werke, Germany) according to the sup-
plier’s instructions.
 Reverse Transcription Polymerase Chain Reaction 
 To investigate mRNA expression of activin A and ActRIB in 
the cochlea, we performed reverse transcription polymerase chain 
reaction (RT-PCR) analysis with isolated RNA from neonatal rat 
organs of Corti, ganglions and stria vascularis. Actin primer was 
used as a positive control for the PCR reaction. Total RNA from 
the brain served as positive control. In the negative control, reac-
tion mixtures without RNA were used. Total RNA was reverse-
transcribed into double-stranded cDNA with the First Strand 
cDNA Synthesis Kit for RT-PCR (Roche, Germany, catalog No. 
11483188001) according to the supplier’s instructions. PCR was 
performed using the PCR Master Mix (Roche, Germany, catalog 
No. 11636103001) with primers specific for activin A and activin 
receptor ActRIB ( fig. 1 a) Sense and antisense primers were used as 
described previously: activin A [Bottner et al., 2006], ActRIB 
[Bottner et al., 2006] and actin [Caelers et al., 2009]. PCR was per-
formed in the Eppendorf Mastercycler (Eppendorf, Germany) un-
der the following conditions: 35 cycles, each cycle consisting of 
denaturation at 94   °   C for 1 min, annealing at 50   °   C for 1 min and 
extension at 72   °   C for 2 min. The PCR products were sequenced 
(Microsynth AG, Switzerland) and visualized under UV light in 
2% agarose gel containing 0.5 kg/ml ethidium bromide [Caelers et 
al., 2009].
 Immunohistochemistry 
 Animal perfusion, decalcification and immunohistochemistry 
were performed as described previously [Monge et al., 2006] with 
primary antibody goat anti-activin A (R&D Systems, UK, catalog 
No. AF338) diluted 1: 75 or 1: 100 or goat anti-activin receptor IB 
(Sigma Aldrich, Germany, catalog No. A2455) diluted 1: 100 or 
1:  200 in 0.15% BSA/PBS (Invitrogen AG, UK) and detected by in-
cubation with rabbit anti-goat biotinylated secondary antibody 
(Santa Cruz Biotechnology Inc., Germany, catalog No. sc-2774). 
Visualization of adult rat slices was performed with 3.3-diamino-
benzidine tetra hydrochloride tablets (Sigma Aldrich, Germany, 
catalog No. D5905), following the supplier’s protocol.
 For fluorescence display, mouse cochleae were dehydrated in 
graded ethanol solutions (at 70, 80, 95, and 3 × 100%, each for 1 h; 
3 × xylene for 1 h; 2 × Paraplast at –60  °  C for 1 h, and Paraplast at 
–60  °  C for 10 h) and embedded in paraffin at 56  °  C. Cochlear par-
affin sections of 10-μm thickness were cut on a Leitz microtome 
and mounted on Superfrost Plus slides (Menzel, Germany). Sec-
tions were deparaffinized, rehydrated, washed in PBS (Invitrogen 
AG, UK) for 5 min and subjected to immunohistochemistry. Mi-
crotome sections of the cochlea were incubated for 1 h at room 
temperature in blocking solution (PBS) containing 1.5% Triton 
X-100 (pH 8, Sigma Aldrich, Germany, catalog No. T8787) and 3% 
normal goat serum. The sections were incubated with primary an-
tibody diluted in PBS-T (PBS containing Triton X-100) with 1% 
normal goat serum overnight at 4  °  C. The following primary anti-
body was used: goat anti-activin receptor IB (1: 100 dilution, Sigma 
Aldrich, Germany, Catalog Number: A2455). After 3 washes in 
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PBS-T, the sections were incubated for 1 h at room temperature 
with the appropriate secondary antibodies rabbit anti-goat IgG Al-
exa Fluor 546 conjugate (1: 250 dilution, Molecular Probes, Invit-
rogen, Switzerland, Catalog Number: A21085) diluted in PBS-T 
with 1% normal goat serum for 2 h at room temperature. After 
washing in PBS, the sections were counterstained with DAPI 
(4’,6-diamidino-2-phenylindole) and mounted on glass slides with 
Mowiol (Fluka, Sigma Aldrich, Switzerland, catalog No. 81381). 
Slices were visualized and photographed using a fluorescence mi-
croscope (Olympus AX-70) equipped with a Spot Insight digital 
camera. Recorded images were adjusted for brightness and con-
trast using Image-Pro Plus and Photoshop image processing soft-
ware.
 With the same method, slices from the same animals (wt and 
tg) were used to detect CaMKII-α, which was used as a promoter 
to generate the tg mice. The following antibodies were used: goat 
anti-CaMKII-α (primary antibody, 1: 200 dilution; Santa Cruz Bio-
technology Inc., Germany, catalog No. sc-5391) and rabbit anti-
goat IgG Alexa Fluor 488 conjugate (secondary antibody, 1: 250 
dilution; Molecular Probes, Invitrogen, Switzerland, catalog No. 
A11078).
 Evaluation of Microscopic Anatomy 
 For hematoxylin-eosin (HE) staining, mouse cochleae were 
dehydrated in graded ethanol solutions (at 70, 80, 95, and 3 × 
100%, each for 1 h; 3 × xylene for 1 h; 2 × Paraplast at –60   °   C for 
1 h, and Paraplast at –60   °   C for 10 h), and embedded in paraffin 
at 56   °   C. Cochlear paraffin sections of 10-μm thickness were cut 
on a Leitz microtome and mounted on Superfrost Plus slides 
(Menzel, Germany). Sections were deparaffinized, rehydrated and 
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 Fig. 1.  a Sequences for primers used for RT-PCR. s = sense; as = 
antisense.  b–d In the stria vascularis, ganglion and organ of Corti 
of neonatal rats, mRNA of activin A ( b ) and ActRIB ( c ) were de-
tected. Total RNA in the brain served as a positive control.  d  Actin 
primer was used as a positive control for the PCR reaction and was 
detected in all analyzed tissues. In the negative control, reaction 
mixtures without RNA were used. 
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washed in distilled water for 5 min. Microtome sections of the co-
chlea were stained with a hematoxylin solution (Sigma Aldrich, 
Switzerland, catalog No. 51275) for 5 min, rinsed with tap water 
for 15 min and immersed in eosin 1% aqueous (Eosin Y disodium 
salt, in deionized water; Sigma Aldrich, Switzerland, catalog No. 
E6003) for 1–2 min. Both solutions should be filtered before use 
(Baxter, catalog No. F2217-150, grade 363, qualitative). The sec-
tions were rinsed in tap water, which was exchanged until the wa-
ter was clear. The sections were dehydrated in ascending alcohol 
solutions (50, 70, 80, 95 ×2, and 100% ×2), cleared with xylene 
(×2) and mounted with Eukitt (Fluka, Sigma Aldrich, Switzerland, 
catalog No. 03989).
 HE-stained slices were visualized on a Leica DMRB light mi-
croscope equipped with a spot digital camera (AxioCam, Zeiss) 
to assess the microscopic anatomy of the mouse cochleae. A hair 
cell count was performed as well as assessment of anatomical 
structures (stria vascularis, ganglion, tectorial membrane, basal, 
membrane, Reissner membrane) comparing wt and tg animals 
in exemplary slices from basal, middle and apical turns in each 
animal.
 Auditory Brainstem Response 
 The method we used has been described previously [Caelers et 
al., 2009].
 Hearing was assessed with auditory brainstem response (ABR) 
thresholds. ABR measures the electrical activity produced along 
the auditory pathway in response to sound. Click sounds were 
generated with a TDT Systems 3 auditory evoked potential work-
station running BioSigRP software (Tucker-Davis Technologies, 
Alachua, Fla., USA). The 10-week-old mice were anesthetized by 
intraperitoneal injection of a combination of ketamine (65 mg/kg 
body weight, Graeub, Switzerland), xylazine hydrochloride (13 
mg/kg body weight, Bayer HealthCare, Germany) and aceproma-
zine (2 mg/kg body weight, FATRO S.p.A., Italy). After loss of the 
withdrawal reflex, the animals were placed on a heating pad in a 
soundproof cage. ABR thresholds were recorded with subcutane-
ous stainless steel electrodes as the potential difference between an 
electrode on the vertex and an electrode on the mastoid, whereas 
the lower back served as ground. Broadband click stimuli (dura-
tion 0.1 ms, rate 10/s) were reduced in intensity from 80 dB sound 
pressure level (SPL) in 5-dB steps. ABR waveforms were averaged 
in response to 500 clicks. The stimuli were delivered through a 
closed acoustic system and were calibrated using a sound level 
meter (precision integrating sound level meter type 2218; Brüel & 
Kjaer, Naerum, Denmark) and an ear simulator (type: 4157; Brüel 
& Kjaer, Naerum, Denmark). Sounds were delivered from a free-
field electrostatic speaker (ES1, TDT) placed into the ear canal. 
The hearing threshold was defined as the lowest intensity that in-
duced the appearance of a visually detectable peak. For further 
information on Materials and Methods, see online supplementary 
material (for all online suppl. material, see www.karger.com/
doi/10.1159/000366152).
 Statistical Analysis 
 ABR data and hair cell count (data not shown) were statisti-
cally analyzed with the Mann-Whitney U test using the IBM SPSS 
Statistics version 22.0 software program. We analyzed click hear-
ing threshold, wave (I–V) amplitude and latency at 80 dB SPL, as 
well as hair cell count (inner and outer hair cells). p < 0.05 was 
considered statistically significant.
 Results 
 Expression of Activin A and Activin Receptor ActRIB 
mRNA in the Cochlea 
 mRNA of activin A and ActRIB was detected in the 
organs of Corti, ganglion and stria vascularis from neo-
natal rats by RT-PCR analysis ( fig. 1 b, c). Actin primer 
was used as a positive control for the PCR reaction and 
was detected in all analyzed tissues ( fig. 1 d). Total RNA 
from the brain served as positive control. In the negative 
control, reaction mixtures without RNA were used. 
 Localization of Activin A and Activin Receptor ActRIB 
in the Cochlea 
 Immunohistochemistry was performed to localize ac-
tivin A and ActRIB in the cochlea ( fig. 2 ). Horizontal tissue 
sections were stained with an anti-activin A or anti-ActRIB 
antibody. Activin A immunoreactivity was found in the in-
ner hair cells (IHC), outer hair cells (OHC) and supporting 
cells of the organ of Corti ( fig. 2 a). ActRIB was immunore-
active in the organ of Corti, that is, in IHC, OHC and sup-
porting cells ( fig. 2 c). This shows an identical expression 
pattern for activin A and ActRIB in the mammalian co-
chlea. Furthermore, the cytoplasm of spiral ganglion cells 
also stained positive for activin A and ActRIB ( fig. 2 b, d). 
No staining was found in the negative controls ( fig. 2 e–h).
 Disruption of Activin Signaling Does Not Alter 
Microscopic Anatomy of the Cochlea and ABR 
Thresholds 
 To investigate activin in the adult cochlea, we used tg 
mice with dnActRIB, as stated previously. These tg mice 
are generated using the CaMKII-α promoter present in 
the cochlea, as described in the literature [Müller et al., 
2006] and therefore enable disruption of activin signaling 
in the cochlea of adult mice. Mutating the ActRIB in a 
manner of truncating this receptor generated dominant-
negative activin type I receptors (dnActRIB) [Zhou et al., 
2000]. If they are expressed in excess, they form heterodi-
mers with type II receptors and the type II receptors be-
come nonfunctional [Müller et al., 2006]. Therefore, the 
type II receptors fail to phosphorylate type I receptors and 
activin signaling is inhibited in vivo [Müller et al., 2006]. 
The fact that activin signaling is being inhibited efficient-
ly is proven by the lack of Smad activation, as shown by 
Müller et al. [2006].
 By immunohistochemistry, we showed the clear ex-
pression of ActRIB in the cochlea of wt mice in contrast 
to the tg animals ( fig. 3 ). This construct served as a suit-
able model to explore the effect of activin signaling dis-
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ruption in the cochlea in vivo. We performed click-ABR, 
inducing distinct ABR waveforms (I–V) and latencies to 
visibly define ABR thresholds for each animal. An exam-
ple of click-induced ABR waveforms and latencies of both 
wt and tg mice is shown until no peak (waveform) is vis-
ibly detectable (threshold;  fig.  4 a). Click-induced ABR 
thresholds between wt and tg mice showed no significant 
difference ( fig. 4 b). The average ABR threshold in wt mice 
was 25 dB SPL (SD, 2.5 dB SPL) and 24.4 dB SPL for tg 
mice (SD, 2.9 dB SPL). Furthermore, we analyzed the 
wave amplitudes and latencies and found no significant 
discrepancy between the two groups (no data shown). 
There was no morphological difference seen in HE-
stained tissue sections ( fig. 5 ) of the organ of Corti, stria 
vascularis, Reissner membrane, tectorial membrane, bas-
al membrane and ganglion cell microscopic anatomy be-
tween the wt and tg animals. Both groups showed at times 
partially ruptured membranes (tectorial membrane, Re-
issner membrane) and/or collapsed tectorial membranes 
in similar rates. Furthermore, the IHC and OHC count of 
the basal, middle and apical turn remained equal and un-
damaged in both groups.
Activina
OHC IHC
ScM
BM DC
b Activin
GC
c ActRIB
ScM
IHC OHC
DC BM
d ActRIB
GC
 Fig. 2.  a ,  b Localization of activin A in the adult rat cochlea by im-
munohistochemistry. ScM  = Scala media; BM  = basilar mem-
brane; DC = Deiters cells; GC = ganglion cells.  a Activin A expres-
sion in IHC, OHC and Deiters cells of the organ of Corti as indi-
cated by the arrows.  b Activin A expression in ganglion cells, 
particularly in the cytoplasm, as indicated by the arrows.  c ,  d Lo-
calization of activin receptor ActRIB in the adult rat cochlea by 
immunohistochemistry.  c ActRIB expression in IHC, OHC and 
Deiters cells of the organ of Corti as indicated by the arrows. 
 d    ActRIB expression in ganglion cells, particularly in the cyto-
plasm, as indicated by the arrows. 
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 Discussion 
 Activin is an essential ligand in the early development 
of mammals [Liu et al., 2007; Natale et al., 2009], leading 
to lethality when activin signaling is disrupted during em-
bryogenesis, as shown in embryonic mice mutants for 
ActRIB [Natale et al., 2009]. Activin signaling is also in-
volved in the development and organogenesis of the co-
chlea [Liu et al., 2007].
 In a unique case study [Furuya et al., 2008] about fi-
brodysplasia ossificans progressiva, the authors reported 
an unusual mutation in the ActRI gene located in the 
noncytosine-phosphate-guanine (non-CpG) region in-
stead of the common mutation in the functionally impor-
tant domain (CpG hot spot) of the ActRI. This newly dis-
covered mutation of the ActRI led to a unique clinical 
picture of fibrodysplasia ossificans progressiva, with a re-
markable slow progression and, among others, sensori-
neural hearing loss. This draws attention towards a re-
markable significance of activin and the ActRI for hearing 
capability.
 In this study, we present for the first time the expres-
sion of activin A and ActRIB in the adult mammalian co-
chlea. Although activin is crucial in embryogenesis, it is 
not known what functions are sustained in developed and 
mature mammals. Activin binds to activin receptors type 
II. Subsequently, it dimerizes with type I receptors in or-
der to initiate a signaling pathway into the nucleus. If, 
Negative control for activin
ScM
OHCIHC
BMDC
e f Negative control for activin
GC
h Negative control for ActRIB
GC
 Fig. 2.  e–h Corresponding negative controls. Images are presented with a 40-fold (organ of Corti) and 63-fold (ganglion cells) magni-
fication. Scale bar = 50 μm. 
g Negative control for ActRIB
OHC
IHC
ScM
BM DC
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however, the ActRIIB is nonfunctional, activin signaling 
cannot be initiated with the help of type I receptors. Trun-
cated ActRIB form a nonfunctional unit with type II re-
ceptors and make them unable to initiate the signaling 
pathway efficiently. We therefore used tg dnActRIB mice 
[Müller et al., 2006] as a model for disruption of activin 
signaling in vivo and showed an absence of function of 
ActRIB in the cochlea. The tg mice were constructed us-
ing the CaMKII-α promoter. Since CaMKII-α is ex-
pressed in the stria vascularis, cochlear hair cells, support-
ing cells and ganglion cells [Agrup et al., 1997; Minamino 
et al., 1998; Puschner and Schacht, 1997] (and our own 
data, not shown), we assumed a dominant-negative effect 
of ActRIB in the cochlea, resulting in the disruption of 
activin signaling. Hearing thresholds were recorded by 
ABR measurements and histological analyses of the mam-
malian cochlea were conducted to assess the effect of the 
presence of activin signaling (and the absence thereof). 
Subsequently, we could not detect any differences in 
hearing thresholds between ActRIB tg and wt mice. 
Moreover, we were able to show that disability of ActRIB 
does not detectably alter cochlear microscopic anatomy. 
Both groups showed at times partially ruptured mem-
branes (tectorial membrane, Reissner membrane) and/or 
collapsed tectorial membranes in similar rates, which we 
assume to be due to fixation. Furthermore, the IHC and 
OHC count of the basal, middle and apical turn remained 
equal and undamaged in both groups. These findings 
suggest that the disruption of activin signaling in vivo 
does not influence hearing and cochlear structure in adult 
mice under physiological circumstances after postnatal 
development.
 Due to the known presence of ActRII in the adult 
mammalian inner ear and the finding of activin A and 
ActRIB in the mammalian inner ear, we postulate an in-
fluence of activin in the mature mammalian cochlea, 
probably under nonphysiological conditions such as dur-
ing and after damaging events in the inner ear. It is worth 
 Fig. 3. Illustration of ActRIB by immunohistochemistry. NF  = 
Nerve fibers; GC = ganglion cells; SV = stria vascularis. In contrast 
to tg mice ( b ,  d ), the wt mice ( a ,  c ) clearly express ActRIB in IHC, 
OHC, Deiters cells, cochlear nerve fibers, cytoplasm of ganglion 
cells, and stria vascularis. Cell nuclei are in blue (DAPI, color in 
online version only), ActRIB in red. Images are presented with a 
40-fold ( a ,  b ) and 10-fold ( c ,  d ) magnification. Scale bar = 100 μm 
( a ,  b ) and 50 μm ( c ,  d ). 
Co
lor
 ve
rsio
n a
vai
lab
le o
nlin
e
NF
wt
OHC IHC
GC
a
tg
OHC
IHC
GCNF
b
SV
tg
d
SV
wt
c
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
5/
27
/2
01
6 
2:
56
:3
5 
PM
 Activin and ActRIB in Mammalian 
Cochlea 
Audiol Neurotol 2015;20:51–61
DOI: 10.1159/000366152
59
noting that we performed our PCR study with material 
from neonatal animals because, at this stage, cochlear mi-
crodissection for RNA isolation can be performed before 
ossification occurs. We must acknowledge the possibility 
that the expression patterns of our data may differ at dis-
tinct developmental stages.
 Activin enhances the survival of neurons in vitro [Iwa-
hori et al., 1997; Krieglstein et al., 1995] or decreases isch-
emic brain injury [Wu et al., 1999] and shields neurons 
against neurotoxic damage [Hughes et al., 1999; Kriegl-
stein et al., 1995] in vivo. Disruption of activin signaling 
yields neurons to be more susceptible to local and distant 
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 Fig. 4. Broadband-click-induced ABR thresholds of wt and tg 
mice.  a An example of click-induced ABR thresholds is shown 
from a wt and a tg dnActRIB mouse.  b The average ABR threshold 
was 25 dB SPL for wt mice (SD, 2.5 dB SPL) and 24.4 dB SPL for 
tg mice (SD, 2.9 dB SPL). In the Mann-Whitney U Test, there was 
no statistical significant difference between the two groups. 
 Fig. 5. Cochlear morphology from adult wt 
and tg dnActRIB mice with HE staining of 
the tissue sections. ScM  = Scala media; 
ScV = scala vestibuli; ScT = scala tympani; 
SV = stria vascularis; TM = tectorial mem-
brane; BM = basilar membrane; DC = Deit-
ers cells; GC = ganglion cells; RM = Reiss-
ner’s membrane. Arrows indicate intact in-
ner and outer hair cells. There was no 
morphological difference detected between 
wt and tg animals in the organ of Corti, 
stria vascularis and ganglion cells. Magni-
fication × 20. Scale bar = 50 μm. 
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excitotoxic injury [Müller et al., 2006]. More recent stud-
ies demonstrated neuroprotective and neuroregenerative 
properties of activin A in the central nervous system with 
in vitro models [Suzuki et al., 2010; Tretter et al., 1996, 
2000]. These observations suggest a beneficial role of ac-
tivin in neuronal functionality, recovery and regenera-
tion, particularly wherever activin receptors are ex-
pressed. Furthermore, the known neuroprotective action 
of basic fibroblast growth factor (bFGF) is reported to 
depend on the induction of activin A in vivo [Tretter et 
al., 2000]. Results provide strong evidence for an essential 
function of endogenous activin A in the neuroprotective 
effect of exogenously administered bFGF [Tretter et al., 
2000]. As mentioned earlier, activin A alone is upregu-
lated after acute brain injury. However, bFGF tremen-
dously augments the induction of activin A [Tretter et al., 
2000]. In mammalian auditory hair cells, bFGF had a pro-
tective effect against aminoglycoside and glutamate neu-
rotoxicity as well as against noise injury [Low et al., 1996; 
Zhai et al., 2002, 2004]. Nevertheless, it is not known 
whether activin is involved in the protective effect of 
bFGF on auditory hair cells in the cochlea. 
 Lately, it is becoming evident that activin is able to 
modulate synaptic plasticity, cognition and affective be-
havior [Krieglstein et al., 2011]. Moreover, activin recep-
tor signaling is implied to be essential for optimizing the 
performance of neuronal circuits in the mature brain 
through NMDA receptor responses [Müller et al., 2006]. 
In addition, activin was found to compensate for declined 
NMDA receptor conditions [Kurisaki et al., 2008]. It is 
therefore tempting to speculate that activin itself bears as 
yet undiscovered influences in the cochlear nervous sys-
tem, playing a role in presbycusis [Tang et al., 2014], pos-
sibly in tinnitus and perhaps in sensorineural hearing loss.
 In light of the noteworthy characteristics of activin as 
a neuroprotectant and modulator of synaptic plasticity in 
the brain, activin may likewise be inducing protective 
characteristics on supporting cells in the mammalian co-
chlea, where ActRII [McCullar et al., 2010] and ActRIB 
are expressed. The supporting cells are in turn liable for 
the homeostasis of cochlear hair cells. A precondition for 
an effect of activin on mammalian auditory hair cells is 
the local expression of activin receptors in the mamma-
lian organ of Corti, as we present in this study.
 However, to date the precise role of activin and its re-
ceptors in the mature cochlea is not known and the ac-
tivin receptor could also be a passive bystander in the in-
ner ear. Future effort is needed to clarify the function of 
activin and its receptors in the mammalian cochlea.
 Conclusion 
 Activin A and ActRIB are expressed within the inner 
ear. ActRIB inoperability with subsequent disruption of 
activin signaling does not alter the microanatomy of the 
cochlea nor do dnActRIB tg mice show different hearing 
thresholds than comparable wt mice. We conclude, there-
fore, that activin signaling is not necessary for hearing in 
adult mice. Future studies are needed to explore the pre-
cise role of activin A in the mature inner ear during phys-
iological and nonphysiological events.
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